Peptide Therapy·Jul 12, 2026
The single biggest predictor of peptide-program safety and margin is not the peptide list — it is how well the clinical staff around the prescriber are trained. This is the six-week curriculum DRS uses with new practices, built for MA / RN / NP roles.
Who to train, and to what standard
- Prescriber (MD / DO / NP / PA): full pharmacology, contraindications, interactions, and current FDA compounding framework. Signs off on every protocol.
- Clinical support (RN / MA): patient intake, injection technique, side-effect triage, documentation, refill workflow. Operates under a delegated protocol.
- Front office: consent handling, cash-pay quoting, pharmacy-of-record logistics, adverse-event escalation script.
Week-by-week curriculum
Week 1 — Foundations
- What a peptide is; how it differs from small molecules and biologics.
- FDA framework: approved peptide drugs vs. compounded peptides vs. research-only.
- The 503A / 503B pharmacy landscape and current permitted bulk lists.
- Read one PepEdHub peptide profile end-to-end and one primary reference.
Week 2 — Metabolic peptides (GLP-1 focus)
- Semaglutide, tirzepatide, retatrutide — mechanism, titration, side-effect management, contraindications (personal / family MTC or MEN 2, pancreatitis).
- The GI side-effect ladder and dose-hold protocol.
- Cardiometabolic reframing after SELECT — how to talk to patients about it.
Week 3 — Growth, repair, and cognitive peptides (education tier)
- GH secretagogues (current permitted vs. restricted list — this changes; check quarterly).
- BPC-157 and TB-500 education tier — current U.S. legal framing, not prescribing.
- How to answer patient questions honestly when a peptide is not appropriate to prescribe.
Week 4 — Injection technique and infection control
- Subcutaneous injection sites, needle size, rotation schedule.
- Reconstitution and stability — bacteriostatic water, storage, beyond-use dates.
- Sharps handling; injection-site reaction triage.
- Live-observed injections × 5 per staff member before independent practice.
Week 5 — Documentation, monitoring, and adverse-event workflow
- Baseline labs by peptide class; monitoring cadence.
- EMR templates for consent, dose, titration, refill, and outcome capture.
- Adverse-event decision tree: continue, hold, dose-reduce, discontinue, escalate.
- MedWatch reporting workflow for serious events.
Week 6 — Patient education and competency sign-off
- The 10-minute new-patient education script.
- Written and observed competency check for each role.
- Sign-off by the prescriber; retention in the personnel file.
- Quarterly re-competency and annual curriculum refresh.
Time budget (realistic)
- MA / RN: ~18 hours over 6 weeks (3 hours / week average).
- NP / PA: ~30 hours over 6 weeks (the pharmacology deep-dive adds ~12 hours).
- Prescriber: ~40 hours over 6 weeks (protocol build, chart-signoff pilots, pharmacy relationships).
Tools DRS provides
- PepEdHub — 95+ peptide profiles, 110+ protocols, 3,400+ curated studies, free for licensed providers.
- PeptideProtocols.ai — decision-support tool that generates evidence-tiered personalized protocols with contraindication screening; the prescriber remains the decision-maker.
- Quarterly virtual bootcamps and in-person device certification days.
The three most common training failures
- Skipping the observed-injection requirement — injection-site infections are almost always technique failures, not product failures.
- Not updating the curriculum when the FDA compounding list changes.
- Letting front-office staff quote medical outcomes to patients — reserve that conversation for the prescriber or trained clinical support.
Related